MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Copper"

  • MDS Virtual Congress 2021

    Long term follow-up of Wilson disease patients in Poland. Report from the national reference centre.

    A. Członkowska, T. Litwin, ł. Kraiński, M. Skowrońska, A. Piechal, A. Antos, M. Niewada (Warszawa, Poland)

    Objective: We present seven decades of experience of a single reference centre covering most adult Wilson disease (WD) patients in Poland. Background: WD is a rare…
  • MDS Virtual Congress 2021

    Impact of ALXN1840 on the neurological symptoms of Wilson disease: secondary outcomes of a phase 2, open-label, single-arm study

    A. Członkowska, S. Moseley, E. Swenson, D. Bega, P. Hedera, D. Nicholl, J. Bronstein (Warsaw, Poland)

    Objective: To evaluate neurological efficacy outcomes of ALXN1840 treatment in adults with Wilson disease (WD) from a phase 2, open-label, single-arm study (NCT02273596). Background: WD…
  • MDS Virtual Congress 2021

    Clinical presentation of Wilson’s disease in pediatric and adult patients: A systematic review

    A. Rochel-Pérez, K. Santos-Zaldivar, O. Cuevas-Koh, M. Azuela-Morales, N. Méndez-Domínguez (Mérida, Mexico)

    Objective: To identify the most frequent signs and symptoms in Wilson's disease comparing between pediatric and adult patients. Background: Wilson's disease or Progressive Lenticular Degeneration…
  • MDS Virtual Congress 2020

    Movement disorders in a family carrying ATP7A variant

    G. Buongarzone, B. Minafra, E. Errichiello, S. Gana, A. Asaro, I. Canavero, E. Tartara, M. Paoletti, R. Zangaglia, C. Cereda, C. Pacchetti, E.M Valente (Pavia, Italy)

    Objective: To report an early onset parkinsonism in a family carrying a pathogenic variant in the ATP7A gene. Background: ATP7A variants cause Menkes disease (MD), a…
  • MDS Virtual Congress 2020

    Late onset Wilson’s disease with hepatic and neurological manifestations

    H.J Kim, D.W Kwack, S.H Kim (Seoul, Republic of Korea)

    Objective: To report a patient with clinically diagnosed late-onset Wilson’s disease (WD). Background: WD is an autosomal recessive disorder of copper biliary excretion caused by…
  • MDS Virtual Congress 2020

    Copper induced neurobehavioral features of Parkinson’s disease and oxidative stress and their abatement by Eugenol

    A. Kumar, B. Sharma (Allahabad, India)

    Objective: The aim of this study was to evaluate impact of copper intoxication (10 mg/kg B.W) for 3 days on locomotor performance and oxidative status,…
  • MDS Virtual Congress 2020

    Cooper-deficiency myeloneuropathy in Wilson´s Disease as a result of D-penicillamine treatment: A case report

    A. Gomes, F. Rolim, K. Menezes, L. Brito, A. Moura, J. Lima, A. Marinho, G. Ferreira, F. Carvalho (Fortaleza, Brazil)

    Objective: To present a case of subacute combined degeneration of the spinal cord secondary to iatrogenic copper deficiency as a result of D-penicillamine therapy. Background:…
  • 2019 International Congress

    Structural imaging changes in hepatic and neurological Wilson disease

    A. Patel, K. Nalamada, A. Vives-Rodriguez, D. Robakis, T. Constable, J. Arora, M. Schilsky, S. Tinaz (New Haven, CT, USA)

    Objective: To quantitatively assess cerebral structural changes in Wilson disease (WD) subjects with hepatic and neurological phenotypes. Background: WD is a rare autosomal recessive disorder…
  • 2019 International Congress

    A case report of Wilson Disease in a Kyrgyz teenager

    A. Jusupova (Bishkek, Kyrgyzstan)

    Objective: Information on the occurrence of WD in the Kyrgyz Republic is currently missing. However, based on previously received epidemiological data to the territories of…
  • 2019 International Congress

    Wislon disease: clinical specificities of the disease course under normal ceruloplasmin in the blood, a clinical case from Kyrgyzstan

    N. Chekeeva (Bishkek, Kyrgyzstan)

    Objective: Apparent clinical picture of Wilson's disease with normal blood ceruloplasmin levels in young patients with Wilson's disease. Background: Wilson's disease is a hereditary disease…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley